—

Scholar Rock Holding Corp (SRRK) — the peer cohort

As of 2026-10-29 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Scholar Rock Holding Corp ranks 7 of 7 in its cohort on the Closelooknet composite (25/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
SRRK Scholar Rock Holding Corp 25 38 1 — info 28.5%
BION.SW BB Biotech AG 74 70 96 81 info 10.2%
HALO Halozyme Therapeutics Inc 73 98 94 38 ok 1%
UCB.BR UCB SA 65 66 71 53 info 2.8%
ARGX.BR Argen-X 64 78 76 28 info 13%
ARGX argenx NV ADR 63 71 75 28 info 16.3%
RIGL Rigel Pharmaceuticals Inc 63 96 90 73 ok 1.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-29

Quick answers

Who are Scholar Rock Holding Corp's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Halozyme Therapeutics Inc (HALO), UCB SA (UCB.BR), Argen-X (ARGX.BR), argenx NV ADR (ARGX), Rigel Pharmaceuticals Inc (RIGL).

How does SRRK score against its peers?

Scholar Rock Holding Corp's composite reads 25/100, ranking 7 of 7 in its cohort as of 2026-10-29; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.